Hypertension is a leading cause of cardiovascular diseases (CVD). The prevalence has doubled from 1990 to 2019 [1] and now impacts almost half of the US adult population [2], and the condition accounts for a major proportion of CVD incidence [3] and burden of death and disability [4]. Hypertension also leads to debilitating, financially costly chronic conditions including kidney disease, stroke, and heart failure. Although numerous therapeutic options are available, this condition is poorly controlled at the population level, as a recent study from the National Health and Nutrition Examination Survey data reported only 43.7 % of the patients in the US in 2017 and 2018 had systolic/diastolic blood pressure below 140/90 mmHg [5] Furthermore, there are increasing global disparities in the prevalence, awareness, treatment and control of hypertension [6].
